Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

214.34
Delayed Data
As of Jan 20
 -0.24 / -0.11%
Today’s Change
184.50
Today|||52-Week Range
301.98
+2.06%
Year-to-Date
How Will Pfizer Inc. Fare Under President Trump?
12:12pm / MotleyFool.com - Paid Partner Content
Allergan (AGN) Rhofade Cream for Rosacea Approved in U.S.
Jan 20 / Zacks.com - Paid Partner Content
Novartis (NVS) Q4 Earnings: Stock Likely to Disappoint?
Jan 20 / Zacks.com - Paid Partner Content
Should Value Investors Choose Allergan (AGN)?
Jan 19 / Zacks.com - Paid Partner Content
Clear Harbor Asset Management, LLC Buys General Motors Co, Qorvo Inc, Toll Brothers I...
Jan 20 / GuruFocus News - Paid Partner Content
Apricus (APRI) Stock Gains on Vitaros' Approval in Mexico
Jan 19 / Zacks.com - Paid Partner Content
Jim Cramer Is No Fan of Retail Stocks in the Age of Amazon
Jan 20 / TheStreet.com - Paid Partner Content
Vertex Pharma (VRTX) Q4 Earnings: Stock Likely to Beat?
Jan 19 / Zacks.com - Paid Partner Content
Synergy Pharmaceuticals Secures Approval for Linzess Competitor
Jan 20 / TheStreet.com - Paid Partner Content
Biogen (BIIB) Q4 Earnings: What's in Store for the Stock?
Jan 19 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close214.58
Today’s open214.76
Day’s range213.13 - 216.07
Volume2,925,807
Average volume (3 months)4,695,046
Market cap$80.4B
Dividend yield1.31%
Data as of 4:01pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-0.01%
Earnings growth (next 5 years)+11.50%
Revenue growth (last year)+15.38%
P/E ratioNM
Price/Sales7.63
Price/Book1.18

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb-6.26-11.28%
LLYEli Lilly and Co-0.03-0.04%
CELGCelgene-0.96-0.84%
ABTAbbott Laboratories+0.06+0.15%
Data as of 4:01pm ET, 01/20/2017

Financials

Next reporting dateFebruary 8, 2017
EPS forecast (this quarter)$3.75
Annual revenue (last year)$15.1B
Annual profit (last year)$3.9B
Net profit margin-19.06%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts


Search for Jobs